Carme Sarries

887 total citations
10 papers, 718 citations indexed

About

Carme Sarries is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Carme Sarries has authored 10 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Carme Sarries's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (4 papers) and DNA Repair Mechanisms (4 papers). Carme Sarries is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (4 papers) and DNA Repair Mechanisms (4 papers). Carme Sarries collaborates with scholars based in Spain, Italy and United States. Carme Sarries's co-authors include Miquel Tarón, Rafael Rosell, José Javier Sánchez, Bárbara Roig, Rafael Rosell, Giorgio V. Scagliotti, José Luis Ramírez, Agustí Barnadas, Pedro Méndez and Mónica Botia and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cancer Letters.

In The Last Decade

Carme Sarries

10 papers receiving 703 citations

Peers

Carme Sarries

MB

ONCOL

PRM

CR

GENET

Haby Henary United States

Michael Andreef United States

Olga Camacho‐Vanegas United States

Peter Häusler Germany

Timo Hillebrand Germany

Motonori Futatsugi Japan

Robin Guo United States

R.E. Kibbelaar Netherlands

Ruixuan Geng China

Adriaan Vanderstichele Belgium

Haby Henary United States

Carme Sarries

376 ×0.8

MB

378 ×1.3

ONCOL

199 ×0.8

PRM

117 ×0.5

CR

59 ×0.6

GENET

Citations per year, relative to Carme Sarries Carme Sarries (= 1×) peers Haby Henary

Countries citing papers authored by Carme Sarries

Since Specialization

Citations

This map shows the geographic impact of Carme Sarries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carme Sarries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carme Sarries more than expected).

Fields of papers citing papers by Carme Sarries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carme Sarries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carme Sarries. The network helps show where Carme Sarries may publish in the future.

Co-authorship network of co-authors of Carme Sarries

This figure shows the co-authorship network connecting the top 25 collaborators of Carme Sarries. A scholar is included among the top collaborators of Carme Sarries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carme Sarries. Carme Sarries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Rosell, Rafael, Yukito Ichinose, Miquel Tarón, et al.. (2005). Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancer. Lung Cancer. 50(1). 25–33. 54 indexed citations

2.

Isla, Dolores, Carme Sarries, Rafael Rosell, et al.. (2004). Single nucleotide polymorphisms and outcome in docetaxel–cisplatin-treated advanced non-small-cell lung cancer. Annals of Oncology. 15(8). 1194–1203. 255 indexed citations

3.

Sarries, Carme, Vicente Alberola, R. de las Peñas, et al.. (2004). Combined DNA repair gene single nucleotide polymorphisms (SNPs) in gemcitabine (gem)/cisplatin (cis)-treated non-small-cell lung cancer (NSCLC) patients (p). Journal of Clinical Oncology. 22(14_suppl). 7031–7031. 1 indexed citations

4.

Sarries, Carme, Vicente Alberola, R. de las Peñas, et al.. (2004). Combined DNA repair gene single nucleotide polymorphisms (SNPs) in gemcitabine (gem)/cisplatin (cis)-treated non-small-cell lung cancer (NSCLC) patients (p). Journal of Clinical Oncology. 22(14_suppl). 7031–7031. 3 indexed citations

5.

Ramírez, José Luis, Carme Sarries, Bárbara Roig, et al.. (2003). Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients. Cancer Letters. 193(2). 207–216. 98 indexed citations

6.

Rosell, Rafael, Miquel Tarón, Agustí Barnadas, et al.. (2003). Nucleotide Excision Repair Pathways Involved in Cisplatin Resistance in Non-Small-Cell Lung Cancer. Cancer Control. 10(4). 297–305. 125 indexed citations

7.

Sarries, Carme, Pilar Garrido, Bárbara Roig, et al.. (2003). P-225 XPD and RRM1 gene polymorphisms predict gemcitabine (gem)/cisplatin (cis)/docetaxel (doc) outcome in stage III non-small-cell lung cancer (NSCLC): a genetic analysis of the Spanish Lung Cancer Group phase II trial 9901. Lung Cancer. 41. S148–S148. 1 indexed citations

8.

Ramírez, José Luis, Miquel Tarón, Carmen Balañá, et al.. (2003). Serum DNA as a tool for cancer patient management.. PubMed. 48. 34–41. 26 indexed citations

9.

Balañá, Carmen, José Luis Ramírez, Miquel Tarón, et al.. (2003). O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.. PubMed. 9(4). 1461–8. 124 indexed citations

10.

Sarries, Carme, Eric B. Haura, Bárbara Roig, et al.. (2002). Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer. Pharmacogenomics. 3(6). 763–780. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact